Evidence map›Paper›PMID 27030340›Full record

ArticleJournal of the American Heart Association2016

Statin and Aspirin Use Among Hispanic and Latino Adults at High Cardiovascular Risk: Findings From the Hispanic Community Health Study/Study of Latinos.

Dima M Qato, Todd A Lee, Ramon Durazo-Arvizu, Donghong Wu, Jocelyn Wilder, Samantha A Reina, Jianwen Cai, Franklyn Gonzalez, Gregory A Talavera, Robert J Ostfeld and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Alteration of oral microbiome composition in children living with pesticide-exposed farm workers.International journal of hygiene and environmental health · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dima M QatoDepartment of Pharmacy Systems, Outcomes and Policy, University of Illinois College of Pharmacy, Chicago, IL Division of Epidemiology and Biostatistics, University of Illinois School of Public Health, Chicago, IL dimaqato@uic.edu.
Todd A LeeDepartment of Pharmacy Systems, Outcomes and Policy, University of Illinois College of Pharmacy, Chicago, IL Division of Epidemiology and Biostatistics, University of Illinois School of Public Health, Chicago, IL.
Ramon Durazo-ArvizuDepartment of Biostatistics, Loyola University Chicago, Chicago, IL Institute for Minority Health Research, University of Illinois College of Medicine, Chicago, IL.
Donghong WuInstitute for Minority Health Research, University of Illinois College of Medicine, Chicago, IL.
Jocelyn WilderDepartment of Pharmacy Systems, Outcomes and Policy, University of Illinois College of Pharmacy, Chicago, IL Division of Epidemiology and Biostatistics, University of Illinois School of Public Health, Chicago, IL.
Samantha A ReinaDepartment of Psychology, University of Miami, Coral Gables, FL.
Jianwen CaiDepartment of Biostatistics, University of North Carolina at Chapel Hill, NC.
Franklyn GonzalezDepartment of Biostatistics, University of North Carolina at Chapel Hill, NC.
Gregory A TalaveraInstitute for Behavioral and Community Health, Graduate School of Public Health, San Diego State University, San Diego, CA.
Robert J OstfeldDepartment of Medicine, Division of Cardiology, Montefiore Medical Center, Bronx, NY.
Martha L DaviglusInstitute for Minority Health Research, University of Illinois College of Medicine, Chicago, IL.

Funding

HISPANIC COMMUNITY HEALTH STUDY-268065233N01HC065233 · HC · COORDINATING CENTER · PI CHAMBLESS, LLOYD E · 2006 to 2006
–
NHLBI NIH HHS N01-HC65233NHLBI NIH HHS N01-HC65234NHLBI NIH HHS N01-HC65236NHLBI NIH HHS N01-HC65237PHS HHS HHSN268201300003I
6 · The paper itself

Abstract

backgroundDespite variations in the prevalence of cardiovascular disease and related risk factors among US Hispanic/Latino adults of diverse backgrounds, there is little information on whether disparities exist in the use of medications for the primary and secondary prevention of cardiovascular disease. We examined the prevalence of statin and aspirin use among diverse US Hispanic/Latino adults at high cardiovascular risk. METHODS AND

resultsA multicenter population-based study, the Hispanic Community Health Study/Study Of Latinos, included a total of 16 415 participants of Mexican, Puerto Rican, Cuban, Dominican, South American, and Central American backgrounds who were aged 18 to 74 years and enrolled between March 2008 and June 2011. Our analyses were limited to 4139 participants considered to be at high cardiovascular risk. Age-adjusted prevalence of statin and aspirin use was 25% and 44%, respectively, overall but varied by Hispanic/Latino background among those at high cardiovascular risk; statin use was significantly higher (P<0.001) among adults of Puerto Rican (33%) and Dominican (28%) backgrounds compared with adults of other backgrounds (Mexican, 24%; Cuban, 22%; Central American, 20%; South American, 22%). There was no difference in aspirin use. After adjusting for health insurance coverage, the difference in prevalence of statin use was substantially reduced among participants with a Puerto Rican background, from an odds ratio of 1.73 (95% CI 1.30-2.31) to 1.30 (95% CI 0.97-1.75), and with a Dominican background, from an odds ratio of 1.45 (95% CI 1.04-2.02) to 1.07 (95% CI 0.75-1.52), in comparison to their counterparts.

conclusionsAmong Hispanic/Latino adults of diverse backgrounds, statin use was more prevalent among adults with Puerto Rican and Dominican backgrounds at high cardiovascular risk. These differences in statin use were explained, in part, by differences in insurance coverage. These findings have important implications for the prevention of disparities in cardiovascular outcomes within the growing US Hispanic/Latino population.

Indexed as

AdolescentAdultAgedAspirinCardiovascular DiseasesCentral AmericaCubaDominican RepublicFemaleHispanic or LatinoHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMexican AmericansMiddle AgedPrevalenceAspirinHydroxymethylglutaryl-CoA Reductase Inhibitorscardiovascular riskdisparitiesHispanic/Latinostatins

Identifiers

PMID27030340
PMCPMC4859281

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.